Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus

Stefan J Lang, Elisabeth M Messmer, Gerd Geerling, Marc J Mackert, Tobias Brunner, Sylvia Dollak, Borislav Kutchoukov, Daniel Böhringer, Thomas Reinhard, Philip Maier, Stefan J Lang, Elisabeth M Messmer, Gerd Geerling, Marc J Mackert, Tobias Brunner, Sylvia Dollak, Borislav Kutchoukov, Daniel Böhringer, Thomas Reinhard, Philip Maier

Abstract

Background: Corneal cross-linking is widely used to treat keratoconus. However, to date, only limited data from randomized trials support its efficacy.

Methods: The efficacy and safety of corneal cross-linking for halting progression of keratoconus were investigated in a prospective, randomized, blinded, placebo controlled, multicentre trial. Twenty-nine keratoconus patients were randomized in three trial centres. The mean age at inclusion was 28 years. Longitudinal changes in corneal refraction were assessed by linear regression. The best corrected visual acuity, surface defects and corneal inflammation were also assessed. These data were analysed with a multifactorial linear regression model.

Results: A total of 15 eyes were randomized to the treatment and 14 to the control group. Follow-up averaged 1098 days. Corneal refractive power decreased on average (+/-standard deviation) by 0.35 +/- 0.58 dioptres/year in the treatment group. The controls showed an increase of 0.11 +/- 0.61 dioptres/year. This difference was statistically significant (p = 0.02).

Conclusions: Our data suggest that corneal cross-linking is an effective treatment for some patients to halt the progression of keratoconus. However, some of the treated patients still progressed, whereas some untreated controls improved. Therefore, further investigations are necessary to decide which patients require treatment and which do not.

Trial registration: NCT00626717, Date of registration: February 20, 2008.

Figures

Fig. 1
Fig. 1
Consort flow-chart. Three patients had an incomplete follow-up of one year. The data were included in the analysis. One patient belonged to the treatment arm, the other two to the placebo group
Fig. 2
Fig. 2
Corneal refractive power for each patient over the time of the follow-up

References

    1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322. doi: 10.1016/0039-6257(84)90094-8.
    1. Tuft SJ, Hassan H, George S, Frazer DG, Willoughby CE, Liskova P. Keratoconus in 18 pairs of twins. Acta Ophthalmol (Copenh) 2012;90:e482–6. doi: 10.1111/j.1755-3768.2012.02448.x.
    1. Sugar J, Macsai MS. What causes keratoconus? Cornea. 2012;31:716–9. doi: 10.1097/ICO.0b013e31823f8c72.
    1. Shapiro MB, France TD. The ocular features of Down’s syndrome. Am J Ophthalmol. 1985;99:659–63. doi: 10.1016/S0002-9394(14)76031-3.
    1. Bawazeer A, Hodge W, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol. 2000;84:834–6. doi: 10.1136/bjo.84.8.834.
    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319. doi: 10.1016/S0039-6257(97)00119-7.
    1. Bühren J, Bischoff G, Kohnen T. Keratoconus: clinical aspects, diagnosis, therapeutic possibilities. Klin Monbl Augenheilkd. 2011;228:923–40. doi: 10.1055/s-0031-1280224.
    1. McMahon TT, Edrington TB, Szczotka-Flynn L, Olafsson HE, Davis LJ, Schechtman KB. Longitudinal changes in corneal curvature in keratoconus. Cornea. 2006;25:296–305. doi: 10.1097/01.ico.0000178728.57435.df.
    1. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97–103. doi: 10.1006/exer.1997.0410.
    1. Spoerl E, Wollensak G, Dittert D-D, Seiler T. Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica. 2004;218:136–40. doi: 10.1159/000076150.
    1. Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004;23:503–7. doi: 10.1097/01.ico.0000105827.85025.7f.
    1. Hayes S, Boote C, Kamma-Lorger CS, Rajan MS, Harris J, Dooley E, et al. Riboflavin/UVA collagen cross-linking-induced changes in normal and keratoconus corneal stroma. PLoS One. 2011;6:e22405. doi: 10.1371/journal.pone.0022405.
    1. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35–40. doi: 10.1080/02713680490513182.
    1. Vetter JM, Tubic-Grozdanis M, Faust M, Lorenz K, Gericke A, Stoffelns BM. Effect of various compositions of riboflavin eye drops on the intraoperative corneal thickness during UVA-cross-linking in keratoconus eyes. Klin Monbl Augenheilkd. 2011;228:509–14. doi: 10.1055/s-0031-1273406.
    1. Messmer EM, Meyer P, Herwig MC, Loeffler KU, Schirra F, Seitz B, et al. Morphological and immunohistochemical changes after corneal cross-linking. Cornea. 2013;32:111–7. doi: 10.1097/ICO.0b013e31824d701b.
    1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–7. doi: 10.1016/S0002-9394(02)02220-1.
    1. Kampik D, Koch M, Kampik K, Geerling G. Corneal riboflavin/UV-A collagen cross-linking (CXL) in keratoconus: two-year results. Klin Monbl Augenheilkd. 2011;228:525–30. doi: 10.1055/s-0031-1273403.
    1. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34:796–801. doi: 10.1016/j.jcrs.2007.12.039.
    1. Saffarian L, Khakshoor H, Zarei-Ghanavati M, Esmaily H. Corneal crosslinking for keratoconus in Iranian patients: Outcomes at 1 year following treatment. Middle East Afr J Ophthalmol. 2010;17:365–8. doi: 10.4103/0974-9233.71600.
    1. Koller T, Pajic B, Vinciguerra P, Seiler T. Flattening of the cornea after collagen crosslinking for keratoconus. J Cataract Refract Surg. 2011;37:1488–92. doi: 10.1016/j.jcrs.2011.03.041.
    1. Asri D, Touboul D, Fournié P, Malet F, Garra C, Gallois A, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg. 2011;37:2137–43. doi: 10.1016/j.jcrs.2011.08.026.
    1. Derakhshan A, Shandiz JH, Ahadi M, Daneshvar R, Esmaily H. Short-term outcomes of collagen crosslinking for early keratoconus. J Ophthalmic Vis Res. 2011;6:155–9.
    1. Viswanathan D, Males J. Prospective longitudinal study of corneal collagen crosslinking in progressive keratoconus. Clin Experiment Ophthalmol. 2013;41:531–6. doi: 10.1111/ceo.12035.
    1. Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg. 2008;24:S720–5.
    1. Wittig-Silva C, Chan E, Islam FMA, Wu T, Whiting M, Snibson GR. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: Three-year results. Ophthalmology. 2014;121:812–21. doi: 10.1016/j.ophtha.2013.10.028.
    1. Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg. 2011;37:149–60. doi: 10.1016/j.jcrs.2010.07.030.
    1. Greenstein SA, Fry KL, Hersh PS. Corneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37:1282–90. doi: 10.1016/j.jcrs.2011.01.029.
    1. O’Brart DPS, Chan E, Samaras K, Patel P, Shah SP. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol. 2011;95:1519–24. doi: 10.1136/bjo.2010.196493.
    1. Sharma N, Suri K, Sehra SV, Titiyal JS, Sinha R, Tandon R, Vajpayee RB. Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol. Feb 2015 [Epub ahead of print].
    1. Pérez-Santonja JJ, Artola A, Javaloy J, Alió JL, Abad JL. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35:1138–40. doi: 10.1016/j.jcrs.2009.01.036.
    1. Eberwein P, Auw-Hädrich C, Birnbaum F, Maier PC, Reinhard T. Corneal melting after cross-linking and deep lamellar keratoplasty in a keratoconus patient. Klin Monbl Augenheilkd. 2008;225:96–8. doi: 10.1055/s-2008-1027128.
    1. Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36:2105–14. doi: 10.1016/j.jcrs.2010.06.067.
    1. Lange C, Böhringer D, Reinhard T. Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A. Graefes Arch Clin Exp Ophthalmol. 2012;250:1689–91. doi: 10.1007/s00417-012-2101-x.
    1. Wollensak G, Hammer T, Herrmann CIA. Haze or calcific band keratopathy after crosslinking treatment? Ophthalmologe. 2008;105:864–5. doi: 10.1007/s00347-008-1831-y.
    1. Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35:1358–62. doi: 10.1016/j.jcrs.2009.03.035.
    1. Maier P, Reinhard T. Riboflavin UVA cross-linking for keratoconus. Ophthalmologe. 2013;110:818–22. doi: 10.1007/s00347-013-2820-3.
    1. Wagner H, Barr JT, Zadnik K. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007;30:223–32. doi: 10.1016/j.clae.2007.03.001.
    1. Burns DM, Johnston FM, Frazer DG, Patterson C, Jackson AJ. Keratoconus: an analysis of corneal asymmetry. Br J Ophthalmol. 2004;88:1252–5. doi: 10.1136/bjo.2003.033670.
    1. Vianna LMM, Muñoz B, Hwang FS, Gupta A, Jun AS. Variability in Oculus Pentacam tomographer measurements in patients with keratoconus. Cornea. 2015;34:285–9.
    1. Hashemi K, Guber I, Bergin C, Majo F. Reduced precision of the Pentacam HR in eyes with mild to moderate keratoconus. Ophthalmology. 2015;122:211–2. doi: 10.1016/j.ophtha.2014.08.026.
    1. Szalai E, Berta A, Hassan Z, Módis L. Reliability and repeatability of swept-source Fourier-domain optical coherence tomography and Scheimpflug imaging in keratoconus. J Cataract Refract Surg. 2012;38:485–94. doi: 10.1016/j.jcrs.2011.10.027.
    1. Gomes JAP, Tan D, Rapuano CJ, Belin MW, Ambrósio R, Guell JL, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34:359–69.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅